O’Neil Green, MBBS, FCCP, and fellow panelists discussed the clinical considerations of barometric pressure on patients with lung conditions such as asthma or COPD.

Paresh C. Giri, MD, FCCP, helped test attendees’ understanding of the diagnostic workup for pulmonary arterial hypertension (PAH) and explored common challenges in distinguishing subtypes.

Isaretta L. Riley, MD, MPH, helped explore best telemedicine practices for patients from underserved populations who require asthma and COPD self-management interventions.

Presenters, including Susan Garwood, MD, discussed hospital system incidental lung nodule programs and the importance of metadata and stratification strategies.

Ajay Sheshadri, MD, MSCI, and fellow panelists shared a snapshot of lung cancer disparities across various populations and discussed ways to bridge the gaps.

Presenters, including Susan Walley, MD, MHCM, NCTTS, analyzed the public health implications of e-cigarette use and vaping, as well as best practices to drive deterrence among young people.

Presenters, including Refika Ersu, MD, outlined the challenges in diagnosing sleep-disordered breathing in pediatric patients, the growing utilization of novel therapies, and the increasing opportunity to use advanced technologies to optimize treatment.

Critical care experts, including Kerry M. Hena, MD, discussed various techniques and tools for conducting rounds and teaching during rounds in the ICU.

CHEST President-Elect, John “Jack” D. Buckley, MD, MPH, FCCP, emphasized the importance of mentoring in helping the organization and its clinicians better reflect the diversity of their patients and society.

Fellows from the University of Oklahoma, the University of Southern California, and the University of Texas Health Science Center at Houston competed in creative clinical trivia and live challenges.

Deji Adegunsoye, MD, PhD, FCCP, reviewed the role of genetic testing in pulmonary fibrosis in the past, present, and future management of the disease.

Diego J. Maselli, MD, FCCP, and other experts provided updates on biologics approved in asthma and in trials for COPD.